HOUGEN ELIZABETH L

CFO Elizabeth Hougen sells 225,220 shares at blended avg $72.43 in 3 transactions; post-sale holding 82,660 shares (-73.2% reduction)

Elizabeth Hougen, EVP Finance & CFO, executed 3 separate sales totaling 225,220 shares on 2026-03-16 and 2026-03-17 for $16,313,675.85, reducing her holdings by 73.2% from 307,880 to 82,660 shares. The sales occurred at prices ($72.38, $72.76, $73.21) near the 52-week high of $86.50, though current price of $71.67 is 17.1% below that peak and the stock has declined 11.1% over the past 30 days. Her prior trades at Ionis show mixed timing: a 2025-09-30 sell achieved a +22.6% 90-day return (poorly timed, as the stock rose after), while two recent 2026 sells have not yet shown measurable 90-day outcomes. The company generated $156,719,000.00 quarterly revenue with an annual growth rate of +33.8%, but posted a net loss of $128,606,000.00 in the latest quarter and has been unprofitable on a full-year basis, creating a disconnect between revenue growth and profitability that may warrant investor scrutiny given the size and timing of the CFO's divestiture.

CFO ELIZABETH L HOUGEN sold 6,988 shares of IONS at $83.24 on 2026-01-30, leaving 132,881 shares; stock near 52-week high.

ELIZABETH L HOUGEN, EVP and CFO, sold 6,988 shares (7.0K shares) at $83.24, representing a -5.0% reduction in her 139,869-share position. The sale occurred near the 52-week high of $83.88, with the stock currently at $83.07. This is her second sale in 14 days (a prior sale occurred on 2026-01-16), suggesting active selling activity in the recent period. Her cross-ticker track record shows 2 prior sells with a 0.00% well-timed rate at the 90-day mark (meaning her prior sales were followed by positive returns, indicating she sold before subsequent gains), though same-ticker outcomes at IONS show 0 of 1 measurable prior sells well-timed. The company faces headwinds: annual revenue declined -10.5%, net income was $-128.6M on quarterly revenue of $156.7M, and the firm remains unprofitable on a full-year basis. Against this backdrop, the CFO's repeated liquidation near 52-week highs warrants observation of whether this pattern continues or how earnings developments unfold.

CFO Elizabeth Hougen sold 12,922 shares of IONS at $75.22 for $971,992.84; now holds 126,307 shares

Elizabeth Hougen, EVP Finance & CFO, sold 12,922 shares at $75.22 on 2026-01-16, reducing her holdings by 9.3%. The stock currently trades at $77.53, above the sale price, indicating this particular transaction was not well-timed relative to subsequent price movement. However, the broader context is material: Ionis reported a net income of $-128.6M against quarterly revenue of $156.7M, with annual revenue declining 10.5% year-over-year and a negative full-year result, signaling the company remains unprofitable. Hougen's prior open-market sell at this ticker (2025-09-30) had a positive 90-day return of 22.6%, meaning that trade was also poorly timed; the insider's cross-ticker timing record shows 0% well-timed sell rate, suggesting a pattern of selling before rallies rather than before declines. The magnitude ($972.0K) and proportion (9.3% reduction) represent a material but not complete exit of her position.

CFO Hougen sold 49,800 IONS shares at $65.26; stock now at 52-week high ($65.80) after +54.3% in 30 days.

CFO Elizabeth L. Hougen sold 49,800 shares at $65.26 on 2025-09-30, reducing her holdings by 31.1% from 160,300 to 110,500 shares. The transaction occurred near the 52-week high, with the stock at current price of $65.80 (+0.0% from 52-week high) and up 54.3% over the preceding 30 days. Despite recent strong price momentum and a quarterly net income of $123.6M, the company posted negative annual net income in its most recent full fiscal year and reported -10.5% annual revenue decline. The timing of this sizable reduction in the CFO's stake coincides with the stock's peak valuation in its recent trading range.